Filing Details
- Accession Number:
- 0000891293-10-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-30 13:00:00
- Reporting Period:
- 2010-07-30
- Filing Date:
- 2010-07-30
- Accepted Time:
- 2010-07-30 19:36:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cell Therapeutics Inc | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1041084 | Phd M Phillip Nudelman | 501 Elliott Ave W, #400 Seattle WA 98119 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-07-30 | 5,800 | $0.39 | 2,529,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 2,000 | $0.39 | 2,527,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 1,600 | $0.39 | 2,525,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 400 | $0.39 | 2,525,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 200 | $0.39 | 2,524,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 11,100 | $0.40 | 2,513,765 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 4,800 | $0.40 | 2,508,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 800 | $0.40 | 2,508,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 8,500 | $0.40 | 2,499,665 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 4,500 | $0.40 | 2,495,165 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 200 | $0.40 | 2,494,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-07-30 | 100 | $0.40 | 2,494,865 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
